人類T細胞雜交瘤細胞；AC5
ScienCell研究實驗室（ScienCell http://www.shijichina.com/goodsid/fenleiyi/3205368_sciencell/1.html）是一家生物技術(shù)公司，主要提供實驗和治療使用細胞和細胞相關(guān)產(chǎn)品。

人類T細胞雜交瘤細胞；AC5

ScienCell研究實驗室（ScienCell /goodsid/fenleiyi/3205368_sciencell/1.html）是一家生物技術(shù)公司，主要提供實驗和治療使用細胞和細胞相關(guān)產(chǎn)品，多種高品質(zhì)正常的人類和動物細胞，細胞培養(yǎng)基和試劑，培養(yǎng)基補充，細胞來源的RNA，基因和蛋白質(zhì)等?？偛吭O(shè)在加利福尼亞州圣迭戈，成立于1999年。細胞培養(yǎng) / ScienCell Research Laboratories (ScienCell) is a biotechnology company whose mission is the research and development of cell and cell-related products for experimental and therapeutic use. The ScienCell technology provides a variety of high quality normal human and animal cells, cell culture media and reagents, medium supplements, cell-derived RNA, cDNA and proteins for the research community. Scientists at ScienCell are also studying and developing cell therapeutic strategies that will significantly improve the quality of life by achieving the cell's ability to combat human degenerative disorders. We are based in San Diego, California and were established in 1999.atcc /

人類T細胞雜交瘤細胞；AC5

ScienCell / Research Laboratories is an expanding biotechnology company whose mission is the research and development of cell and cell-related products for experimental and therapeutic use. The ScienCell technology provides a variety of high quality normal human and animal cells, cell culture media and reagents, cell growth supplements, cell-derived DNA, RNA, and proteins, cell-based assay kits, and stem cell products for the research community. To complement our vast array of primary cells, we offer specialty medium designed to selectively promote unique cell growth, including STEMium™, which allows for the optimal growth of human pluripotent stem cells under feeder-free condition. Scientists at ScienCell are also studying and developing cell therapeutic strategies that will significantly improve the quality of life by utilizing the cell's ability to combat human degenerative disorders. We are based in San Diego, California and established in 1999.